Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Oncogenic activation of Pak1-dependent pathway of macropinocytosis determines BCG entry into bladder cancer cells.

Redelman-Sidi G, Iyer G, Solit DB, Glickman MS.

Cancer Res. 2013 Feb 1;73(3):1156-67. doi: 10.1158/0008-5472.CAN-12-1882.

2.

Specific binding of bacillus Calmette-Guérin to urothelial tumor cells in vitro.

Schneider B, Thanhäuser A, Jocham D, Loppnow H, Vollmer E, Galle J, Flad HD, Ulmer AJ, Böhle A.

World J Urol. 1994;12(6):337-44.

PMID:
7881473
3.

Mycobacterium bovis osteomyelitis involving a hip arthroplasty after intravesicular bacille Calmette-Guérin for bladder cancer.

Guerra CE, Betts RF, O'Keefe RJ, Shilling JW.

Clin Infect Dis. 1998 Sep;27(3):639-40.

PMID:
9770167
4.

A report of iliac muscle abscess due to Mycobacterium bovis after bacillus Calmette-Guerin therapy for bladder cancer.

Talluri SK, Marigowda L, Besur S, Talluri J, Forstall GJ.

South Med J. 2010 Apr;103(4):369-70. doi: 10.1097/SMJ.0b013e3181d38ff1.

PMID:
20224496
5.

Superficial bladder tumors and increased reactivity against mycobacterial antigens before bacillus Calmette-Guerin therapy.

Zlotta AR, Drowart A, Van Vooren JP, Shekarsarai H, De Cock M, Pirson M, Palfliet K, Jurion F, Simon J, Schulman CC, Huygen K.

J Urol. 1998 Jun;159(6):1885-91.

PMID:
9598481
6.

Subversion of CtBP1-controlled macropinocytosis by human adenovirus serotype 3.

Amstutz B, Gastaldelli M, Kälin S, Imelli N, Boucke K, Wandeler E, Mercer J, Hemmi S, Greber UF.

EMBO J. 2008 Apr 9;27(7):956-69. doi: 10.1038/emboj.2008.38. Epub 2008 Mar 6.

7.

Analysis of small GTPase signaling pathways using p21-activated kinase mutants that selectively couple to Cdc42.

Reeder MK, Serebriiskii IG, Golemis EA, Chernoff J.

J Biol Chem. 2001 Nov 2;276(44):40606-13. Epub 2001 Aug 20.

8.
10.
11.
12.

Human neutrophils utilize a Rac/Cdc42-dependent MAPK pathway to direct intracellular granule mobilization toward ingested microbial pathogens.

Zhong B, Jiang K, Gilvary DL, Epling-Burnette PK, Ritchey C, Liu J, Jackson RJ, Hong-Geller E, Wei S.

Blood. 2003 Apr 15;101(8):3240-8. Epub 2003 Jan 2.

13.

Mycobacterial infection after intravesical bacillus Calmette-Guërin treatment for bladder cancer: a case report.

Park CH, Jang MA, Ahn YH, Hwang YY, Ki CS, Lee NY.

Korean J Lab Med. 2011 Jul;31(3):197-200. doi: 10.3343/kjlm.2011.31.3.197. Epub 2011 Jun 28.

14.

Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer.

Simons MP, Nauseef WM, Griffith TS.

Immunol Res. 2007;39(1-3):79-93. Review.

PMID:
17917057
15.

What are the immunologically active components of bacille Calmette-Guérin in therapy of superficial bladder cancer?

Zlotta AR, Van Vooren JP, Denis O, Drowart A, Daffé M, Lefèvre P, Schandene L, De Cock M, De Bruyn J, Vandenbussche P, Jurion F, Palfliet K, Simon J, Schulman CC, Content J, Huygen K.

Int J Cancer. 2000 Sep 15;87(6):844-52.

16.

The fibronectin attachment protein of bacillus Calmette-Guerin (BCG) mediates antitumor activity.

Sinn HW, Elzey BD, Jensen RJ, Zhao X, Zhao W, Ratliff TL.

Cancer Immunol Immunother. 2008 Apr;57(4):573-9. Epub 2007 Sep 5.

PMID:
17786441
17.

BCG in the treatment of superficial cancer of the bladder: a review.

Friberg S.

Med Oncol Tumor Pharmacother. 1993;10(1-2):31-6. Review.

PMID:
8258992
18.

Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling.

Koivusalo M, Welch C, Hayashi H, Scott CC, Kim M, Alexander T, Touret N, Hahn KM, Grinstein S.

J Cell Biol. 2010 Feb 22;188(4):547-63. doi: 10.1083/jcb.200908086. Epub 2010 Feb 15. Erratum in: J Cell Biol. 2010 Apr 19;189(2):385.

19.

Activation of p21-activated kinase 1 is required for lysophosphatidic acid-induced focal adhesion kinase phosphorylation and cell motility in human melanoma A2058 cells.

Jung ID, Lee J, Lee KB, Park CG, Kim YK, Seo DW, Park D, Lee HW, Han JW, Lee HY.

Eur J Biochem. 2004 Apr;271(8):1557-65.

20.

BCG and the treatment of superficial bladder cancer.

Moss JT, Kadmon D.

DICP. 1991 Dec;25(12):1355-67. Review.

PMID:
1815434

Supplemental Content

Support Center